These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 71631)

  • 41. Effect of bromocriptine on maturity onset diabetes.
    Barnett AH; Chapman C; Gailer K; Hayter CJ
    Postgrad Med J; 1980 Jan; 56(651):11-4. PubMed ID: 6992131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Experiences with bromocriptine treatment in acromegaly--a preliminary report.
    Nilsson A
    Acta Endocrinol Suppl (Copenh); 1978; 216():217-24. PubMed ID: 274038
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cellular magnesium levels and the use of penicillamine in the treatment of Huntington's chorea.
    Haslam MT
    J Neurol Neurosurg Psychiatry; 1967 Apr; 30(2):185-8. PubMed ID: 4226749
    [No Abstract]   [Full Text] [Related]  

  • 44. [Therapy of Huntington's chorea: a pharmacological and clinical approach to the organization of the basal ganglia].
    Roccatagliata G; Albano C
    Clin Ter; 1980 Aug; 94(3):249-56. PubMed ID: 6450021
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of dopamine on plasma growth hormone and prolactin levels in normal and acromegalic subjects.
    Camanni F; Massara F; Belforte L; Rosatello A; Molinatti GM
    J Clin Endocrinol Metab; 1977 Mar; 44(3):465-73. PubMed ID: 838847
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Disorders associated with Huntington's chorea].
    Petit H; Destee A
    Nouv Presse Med; 1977 Sep; 6(31):2775. PubMed ID: 145585
    [No Abstract]   [Full Text] [Related]  

  • 47. [Response of growth hormone to sandostatin and bromocriptine and prognostic value of prolactin levels in serum and thyroliberin test in patients with active acromegaly].
    Gasińska T; Nowak S
    Endokrynol Pol; 1993; 44(4):455-65. PubMed ID: 8055814
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bromocriptine and dopaminergic function in Huntington disease.
    Loeb C; Roccatagliata G; Albano C; Besio G
    Neurology; 1979 May; 29(5):730-4. PubMed ID: 155784
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Therapy with bromocriptine and behavior of various hormones in psoriasis patients].
    Valentino A; Fimiani M; Bilenchi R; Castelli A; Francini G; Gonnelli S; Gennari C; Andreassi L
    Boll Soc Ital Biol Sper; 1984 Oct; 60(10):1841-4. PubMed ID: 6097291
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibitory effect of an ergoline derivative, methergoline, on growth hormone and prolactin levels in acromegalic patients.
    Chiodini PG; Liuzzi A; Muller EE; Botalla L; Cremascoli G; Oppizzi G; Verde G; Silvestrini F
    J Clin Endocrinol Metab; 1976 Aug; 43(2):356-63. PubMed ID: 950367
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bromocriptine in the treatment of advanced breast cancer.
    Barrett A; Morgan L; Raggatt PR; Hobbs JR
    Clin Oncol; 1976 Dec; 2(4):373-7. PubMed ID: 1037393
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of bromoergocriptine on TRH-induced growth hormone and prolactin release in acromegalic patients.
    Ishibashi M; Yamaji T; Kosaka K
    J Clin Endocrinol Metab; 1977 Aug; 45(2):275-9. PubMed ID: 407240
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum levels of phenylalanine and tyrosine in Huntington's chorea.
    Ottosson JO; Rapp W
    Acta Psychiatr Scand Suppl; 1971; 221():89-1. PubMed ID: 4255685
    [No Abstract]   [Full Text] [Related]  

  • 54. Letter: Plasma concentration of free choline in patients with Huntington's chorea on high doses of choline chloride.
    Aquilonius SM; Eckernäs SA
    N Engl J Med; 1975 Nov; 293(21):1105-6. PubMed ID: 126381
    [No Abstract]   [Full Text] [Related]  

  • 55. Homovanilic acid in Huntington's disease and Sydenham's chorea.
    Cunha L; Oliveira CR; Diniz M; Amaral R; Conçalves AF; Pio-Abreu J
    J Neurol Neurosurg Psychiatry; 1981 Mar; 44(3):258-61. PubMed ID: 6453208
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuroendocrine function in Huntington's disease: dopaminergic regulation of prolactin release.
    Caine E; Kartzinel R; Ebert M; Carter AC
    Life Sci; 1978 Mar; 22(10):911-8. PubMed ID: 147978
    [No Abstract]   [Full Text] [Related]  

  • 57. [Symptomatic therapy in a possible animal model for Huntington's chorea].
    Schneider G; Oepen H; Klapproth A
    Arzneimittelforschung; 1981; 31(3):437-41. PubMed ID: 6452881
    [TBL] [Abstract][Full Text] [Related]  

  • 58. No effect of bromocriptine in acromegaly: a controlled trial.
    Lindholm J; Riishede J; Vestergaard S; Hummer L; Faber O; Hagen C
    N Engl J Med; 1981 Jun; 304(24):1450-4. PubMed ID: 7015129
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bromocriptine-induced pregnancy in an acromegalic patient.
    Luboshitzky R; Dickstein G; Barzilai D
    JAMA; 1980 Aug; 244(6):584-6. PubMed ID: 7392156
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of acromegaly by dibromoergocryptine and cyproheptadine (author's transl)(proceedings)].
    Mornex R; Berthezene F; Claustrat B; Fischer C
    Ann Endocrinol (Paris); 1976; 37(4):303-4. PubMed ID: 1037362
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.